Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types

Cephalalgia

Volumn 18, Issue 5, 1998, Pages 273-277

  Ashford, E ^a   Salonen, R ^b   Saiers, J ^b   Woessner, M ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SUMATRIPTAN;

ADULT; AEROSOL; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRANASAL; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 0031857924     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1998.1805273.x     Document Type: Article

References (8)

1. Ryan R, Elkind A, Baker CC, Mullican W, DeBussey S, Asgharnejad M. Sumatriptan nasal spray for the acute treatment of migraine: results of two clinical studies. Neurology 1997;49:1225-30
2. Becker WJ, et al. A placebo-controlled, dose-defining study of sumatriptan nasal spray in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, editors. Headache treatment: trial methodology and new drugs. Philadelphia, PA: Lippincott-Raven, 1997
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:1-96
4. Scott AK, Walley AM, Breckenridge T, Lacey LF, Fowler PA. Lack of an interaction between propranolol and sumatriptan. Br J Clin Pharmacol 1991;32:581-4
5. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJN, Baber NS. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol 1991;31:291-4
6. Van Hecken AM, Depres M, DeSchepper PJ, Fowler PA, Lacey LF, Durham JM. Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers. Br J Clin Pharmacol 1992;34:82-4
7. Diamond S. The use of sumatriptan in patients on monoamine oxidase inhibitors. Neurology 1994;45:1039-40
8. Mathew NT, Tietjen GE, Lucker C. Serotonin syndrome complicating migraine pharmacotherapy. Cephalalgia 1996; 16:323-7